igeahub.com
Pfizer Announces Positive Top-Line Results for the Clinical Trial of IBRANCE® - IgeaHub
April 19, 2016 Pfizer Inc. has announced positive top-line results from the Phase 3 PALOMA-2 trial for IBRANCE®, an oral, first-in-class inhibitor of